Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta
| Autor: | Elio Scarpini, Maria Pia Amato, Giuseppe Orefice, G. Vacca, Lorenzo De Santi, Pasquale Annunziata, Davide Maimone, Gianluca Moscato, Raffaella Clerici, Emilio Portaccio, Alfonso Iudice, Antonio Giorgio, Valentina Zipoli, Vincenzo Brescia Morra |
|---|---|
| Přispěvatelé: | Annunziata, P, Giorgio, A, De Santi, L, Zipoli, V, Portaccio, E, Amato, Mp, Clerici, R, Scarpini, E, Moscato, G, Iudice, A, Vacca, G, Orefice, Giuseppe, BRESCIA MORRA, Vincenzo, Maimone, D. |
| Jazyk: | angličtina |
| Rok vydání: | 2006 |
| Předmět: |
Adult
Central Nervous System Male medicine.medical_specialty multiple sclerosis oligoclonal IgG bands Gastroenterology cerebrospinal fluid Central nervous system disease Cerebrospinal fluid oligoclonal bands Disability Evaluation Cerebrospinal fluid Multiple Sclerosis Relapsing-Remitting Interferon β Internal medicine medicine Humans Disability progression interferon-beta disability Autoantibodies Retrospective Studies business.industry Multiple sclerosis Oligoclonal Bands Middle Aged medicine.disease Prognosis Magnetic Resonance Imaging Surgery Treatment Outcome Neurology Relapsing remitting Cohort Disease Progression Female Neurology (clinical) business Biomarkers |
| Popis: | To assess the role of CSF oligoclonal bands (OB) in determining the clinical outcome in patients with relapsing-remitting multiple sclerosis (RRMS) treated with IFN-β, we carried out a retrospective, multicentre, observational study recruiting 209 RRMS patients from six MS centres from northern, central and southern areas of Italy under treatment with IFN-β-1a i.m., IFN-β-1a s.c. and IFN-β-1b s.c. Twenty-two of 209 patients (10.6%) showed no OB in CSF. The patients without had, at disease onset, significantly higher frequency of visual disturbances ( p = 0.02) and less sensory involvement ( p = 0.04) than those with OB. A statistical trend ( p = 0.056) towards a longer time to reach sustained disability progression during treatment was found in patients without compared to those with OB. Thirty-six of 187 (19%) patients with OB worsened by at least 1 EDSS point compared to none of 22 (0%) OB-negative patients ( p = 0.017). The delaying of disability progression in OB-negative patients during treatment was significantly dependent only on the number of baseline MRI T2-weighted lesions ( p = 0.012) that was found to be significantly lower in OB-negative than in OB-positive patients ( p = 0.04). The absence of OB and low number of baseline T2-weighted lesions in this cohort of MS patients are favourable prognostic factors influencing the clinical response to IFN-β treatment in RRMS patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|